Ross Ta MacGillivray

Title: The Innovations of Ross Ta MacGillivray

Introduction

Ross Ta MacGillivray is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant transferrins. His work has implications for medical therapies and research applications.

Latest Patents

MacGillivray holds a patent for "Recombinant transferrins, transferrin half-molecules and mutants thereof." This patent describes recombinant transferrin molecules that are expressed in functional form by stable eukaryotic cell lines, such as baby hamster kidney cells transformed with an expression vector encoding the recombinant molecule. The recombinant transferrins can be utilized in metal chelation therapy to bind and eliminate excess toxic metals in patients suffering from metal overloads. Additionally, they can serve as tissue culture medium supplements or replacements.

Career Highlights

Throughout his career, MacGillivray has focused on advancing the understanding and application of transferrins in various medical contexts. His innovative approach has led to the development of new therapeutic options for patients with metal overload conditions.

Collaborations

Some of his notable coworkers include Walter D Funk and Anne B Mason. Their collaborative efforts have contributed to the success of MacGillivray's research and patent developments.

Conclusion

Ross Ta MacGillivray's work in recombinant transferrins showcases his commitment to innovation in biotechnology. His contributions have the potential to significantly impact medical therapies and research methodologies.